Investors

UNION is a privately held, clinical stage, pharmaceutical company dedicated to the development of a class molecules exhibiting both microbiological and immunomodulatory effects. UNION is focused on the treatment of inflammatory skin disease, but the chemistry platform and its versatile modes of action is widely applicable across a wide range of diseases.

The company has raised funds through non-dilutive sources, the European Investment Bank as well as private investors.

For more information, please contact: 

investor@uniontherapeutics.com
+45 2381 5487